Answers are grounded in this paper and cite their sources.
No AccessJournal of Urology1 Dec 1966The Prophylactic Use of Thio-Tepa in Transitional Cell Carcinoma of the Bladder John W. Wescott John W. WescottJohn W. Wescott More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)63381-0AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1966 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited by Maeda H (1997) Pharmacological Uniqueness and Clinical Effects of Neocarzinostatin Neocarzinostatin, 10.1007/978-4-431-66914-2_11, (205-226), . Batts C (2016) Adjuvant Intravesical Therapy for Superficial Bladder CancerAnnals of Pharmacotherapy, 10.1177/106002809202601016, VOL. 26, NO. 10, (1270-1276), Online publication date: 1-Oct-1992. Richie J (1992) INTRAVESICAL CHEMOTHERAPYUrologic Clinics of North America, 10.1016/S0094-0143(21)00418-3, VOL. 19, NO. 3, (521-527), Online publication date: 1-Aug-1992. Fisher H (1987) Intravesical Chemotherapy for Bladder Tumors Cancer Chemotherapy by Infusion, 10.1007/978-94-009-3193-0_40, (538-559), . Flanigan R, Ellison M, Butler K, Gomella L and McRoberts J (2018) A Trial of Prophylactic Thiotepa or Mitomycin C Intravesical Therapy in Patients with Recurrent or Multiple Superficial Bladder CancersJournal of Urology, VOL. 136, NO. 1 Part 1, (35-37), Online publication date: 1-Jul-1986.Nissenkorn I, Servadio C, Vilikowski E and Glanz I (2018) Long-Term Intravesical Thiotepa Treatment in Patients With Superficial Bladder Tumors and Vesicoureteral RefluxJournal of Urology, VOL. 133, NO. 2, (198-199), Online publication date: 1-Feb-1985. Provinciali R (2018) I Risultati Degli Interventi ChirurgiciUrologia Journal, 10.1177/039156038405100109, VOL. 51, NO. 1, (39-48), Online publication date: 1-Feb-1984. Intini C (1984) Intravesical doxorubicin for the prophylaxis of superficial bladder tumors. A multicenter studyCancer, 10.1002/1097-0142(1984)54:4<756::AID-CNCR2820540428>3.0.CO;2-C, VOL. 54, NO. 4, (756-761), . Soloway M and Ford K (2018) Thiotepa-induced Myelosuppression: Review of 670 Bladder InstillationsJournal of Urology, VOL. 130, NO. 5, (889-891), Online publication date: 1-Nov-1983. Walzer Y, Matheny R, Blatnik A and Soloway M (1983) Urothelial trauma ? A mechanism of tumor promotion?World Journal of Urology, 10.1007/BF00326753, VOL. 1, NO. 2, (100-102), Online publication date: 1-Jun-1983. Jakse G, Hofst�dter F, Engelmann U and Jacobi G (1983) ABH-antigenicity of transitional cell carcinoma of the urinary bladder in patients subjected to topical chemoprophylaxisWorld Journal of Urology, 10.1007/BF00326748, VOL. 1, NO. 2, (82-85), Online publication date: 1-Jun-1983. Lum B (1983) Intravesical Chemotherapy of Superficial Bladder Cancer Urologic Cancer: Chemotherapeutic Principles and Management, 10.1007/978-3-642-81994-0_2, (3-36), . Agnelli G, Gresele P, de Cunto M and del Favero A (1982) Early onset life-threatening myelosuppression after low dose of intravesical thiotepaPostgraduate Medical Journal, 10.1136/pgmj.58.680.380, VOL. 58, NO. 680, (380-381), Online publication date: 1-Jun-1982. Prout G and Hagen I (1982) Chemotherapy of Superficial Bladder Carcinoma Genitourinary Cancer 1, 10.1007/978-94-009-7436-4_6, (143-167), . Schulman C (1982) Intravesical Chemotherapy for Superficial Bladder Tumors Clinical Bladder Cancer, 10.1007/978-1-4613-3353-1_13, (101-111), . ENGLAND H, FLYNN J, PARIS A and BLANDY J (1981) Early Multiple-dose Adjuvant Thiotepa in the Control of Multiple and Rapid TI Tumour NeogenesisBritish Journal of Urology, 10.1111/j.1464-410X.1981.tb03267.x, VOL. 53, NO. 6, (588-592), Online publication date: 1-Dec-1981. Jakse G, Bauer H, Wieland W and Jacobi G (1981) Rezidivprophylaxe durch intravesikale Instillationen mit Adriamycin, Mitomycin-C oder VM-26 beim pTA-1 Blasenkarzinom Verhandlungsbericht der Deutschen Gesellschaft für Urologie, 10.1007/978-3-642-81706-9_99, (351-352), . Soloway M and Masters S (1980) Urothelial susceptibility to tumor cell implantation influence of cauterizationCancer, 10.1002/1097-0142(19800901)46:5<1158::AID-CNCR2820460514>3.0.CO;2-E, VOL. 46, NO. 5, (1158-1163), Online publication date: 1-Sep-1980. Soloway M (2018) Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, VOL. 123, NO. 4, (461-466), Online publication date: 1-Apr-1980. SOLOWAY M (2018) The Management of Superficial Bladder CancerCancer, 10.1002/cncr.1980.45.s7.1856, VOL. 45, (1856-1865), Online publication date: 1-Apr-1980. Murphy W and Soloway M (1980) The effect of thio-TEPA on developing and established mammalian bladder tumorsCancer, 10.1002/1097-0142(19800301)45:5<870::AID-CNCR2820450508>3.0.CO;2-H, VOL. 45, NO. 5, (870-875), Online publication date: 1-Mar-1980. Sakamoto S, Ogata J, Ikegami K and Maeda H (1980) Chemotherapy for bladder cancer with neocarzinostatin: Evaluation of systemic administrationEuropean Journal of Cancer (1965), 10.1016/0014-2964(80)90115-2, VOL. 16, NO. 1, (103-113), Online publication date: 1-Jan-1980. Schulman C (1980) Adjuvant Therapy of T1 Bladder Carcinoma : Preliminary Results of an EORTC Randomised Study Bladder Tumors and other Topics in Urological Oncology, 10.1007/978-1-4613-3030-1_71, (347-354), . Nocks B, Nieh P and Prout G (2018) A Longitudinal Study of Patients with Superficial Bladder Carcinoma Successfully Treated with Weekly Intravesical Thio-TEPAJournal of Urology, VOL. 122, NO. 1, (27-29), Online publication date: 1-Jul-1979. Csellár M and Csontai Á (1979) Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladderInternational Urology and Nephrology, 10.1007/BF02082809, VOL. 11, NO. 1, (39-44), Online publication date: 1-Mar-1979. Schulman C, Sylvester R, Robinson M, Smith P, Lachand A, Denis L, Pavone-Macaluso M, De Pauw M and Staquet M (1979) Adjuvant Therapy of T1 Bladder Carcinoma: Preliminary Results of an EORTC Randomized Study Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease II, 10.1007/978-3-642-81332-0_51, (338-345), . Gavrell G, Lewis R, Meehan W and Leblanc G (2018) Intravesical Thio-tepa in the Immediate Postoperative Period in Patients with Recurrent Transitional Cell Carcinoma of the BladderJournal of Urology, VOL. 120, NO. 4, (410-411), Online publication date: 1-Oct-1978.Nakazono M and Iwata S (2018) A Preliminary Study of Chemotherapeutic Treatment for Bladder TumorsJournal of Urology, VOL. 119, NO. 5, (598-600), Online publication date: 1-May-1978.Nieh P, Daly J, Heaney J, Heney N and Prout G (2018) The Effect of Intravesical Thio-tepa on Normal and Tumor UrotheliumJournal of Urology, VOL. 119, NO. 1, (59-61), Online publication date: 1-Jan-1978. Loening S (1978) Die onkologische Therapie des Harnblasenkarzinoms 29. Tagung vom 21. September bis 24. September 1977 in Stuttgart, 10.1007/978-3-642-81222-4_6, (26-34), . Dobrzecki W and Kaczmarek A (1977) The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumoursInternational Urology and Nephrology, 10.1007/BF02082016, VOL. 9, NO. 2, (145-149), Online publication date: 1-Jun-1977. Lunglmayr G (1977) Resorption von Proteasen und Amylasen bei Geschwulstbefall der HarnblaseEuropean Surgery, 10.1007/BF02601089, VOL. 9, NO. 1, (11-14), Online publication date: 1-Jan-1977. BURNAND K, BOYD P, MAYO M, SHUTTLEWORTH K and LLOYD-DAVIES R (1976) Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 10.1111/j.1464-410X.1976.tb02742.x, VOL. 48, NO. 1, (55-59), Online publication date: 1-Feb-1976. Soloway M and Martino C (1976) Prophylaxis of bladder tumor implantation Intravesical and systemic chemotherapyUrology, 10.1016/0090-4295(76)90557-4, VOL. 7, NO. 1, (29-34), Online publication date: 1-Jan-1976. Hisazumi H, Uchibayashi T, Naito K, Misaki T and Miyazaki K (2018) The Prophylactic Use of Thio-Tepa and Urokinase in Transitional Cell Carcinoma of the Bladder: A Preliminary ReportJournal of Urology, VOL. 114, NO. 3, (394-398), Online publication date: 1-Sep-1975.Mishina T, Oda K, Murata S, Ooe H, Mori Y and Takahashi T (2018) Mitomycin C Bladder Instillation Therapy for Bladder TumorsJournal of Urology, VOL. 114, NO. 2, (217-219), Online publication date: 1-Aug-1975. Veenema R, Romas N and Fingerhut B (1974) Chemotherapy for bladder cancerUrology, 10.1016/S0090-4295(74)80001-4, VOL. 3, NO. 2, (135-139), Online publication date: 1-Feb-1974. Lunglmayr G, Czech K, Zekert F and Kellner G (1973) Bladder hyperthrmia in the treatment of vesical papillomatosisInternational Urology and Nephrology, 10.1007/BF02081753, VOL. 5, NO. 1, (75-84), Online publication date: 1-Mar-1973. Oravisto K (2009) Optimal Intravesical Dosage of Thio-Tepa in the Prophylaxis of Recurrent Bladder PapillomatosisScandinavian Journal of Urology and Nephrology, 10.3109/00365597209132075, VOL. 6, NO. 1, (26-28), Online publication date: 1-Jan-1972. Lunglmayr G and Czech K (2018) Absorption Studies on Intraluminal Thio-Tepa for Topical Cytostatic Treatment of Low-Stage Bladder TumorsJournal of Urology, VOL. 106, NO. 1, (72-74), Online publication date: 1-Jul-1971. Mitchell R (2008) INTRAVESICAL THIOTEPA IN THE TREATMENT OF TRANSITIONAL CELL BLADDER CARCINOMABritish Journal of Urology, 10.1111/j.1464-410X.1971.tb12024.x, VOL. 43, NO. 2, (185-188) Watne A (1970) Solid tumor chemotherapyThe American Journal of Surgery, 10.1016/0002-9610(70)90052-8, VOL. 119, NO. 3, (279-287), Online publication date: 1-Mar-1970. Yeenema R, Dean A, Uson A, Roberts M and Longo F (2018) Thiotepa Bladder Instillations: Therapy and Prophylaxis for Superficial Bladder TumorsJournal of Urology, VOL. 101, NO. 5, (711-715), Online publication date: 1-May-1969.Crassweller P, Ley D and Ranking G (2018) The Use of Nitrogen Mustard for Prevention of Bladder Tumor RecurrenceJournal of Urology, VOL. 100, NO. 1, (21-23), Online publication date: 1-Jul-1968. Volume 96Issue 6December 1966Page: 913-918 Advertisement Copyright & Permissions© 1966 by The American Urological Association Education and Research, Inc.MetricsAuthor Information John W. Wescott More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
John W. Wescott (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: